Organogenesis Holdings
ORGO
142 hedge funds and large institutions have $823M invested in Organogenesis Holdings in 2021 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 54 increasing their positions, 19 reducing their positions, and 20 closing their positions.
205% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 20
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
184% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 19
82% more capital invested
Capital invested by funds: $452M → $823M (+$371M)
41% more funds holding
Funds holding: 101 → 142 (+41)
19.53% more ownership
Funds ownership: 19.42% → 38.95% (+20%)
5% more call options, than puts
Call options by funds: $1.29M | Put options by funds: $1.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$88.2M |
| 2 |
DM
Deerfield Management
New York
|
+$78.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$72M |
| 4 |
Morgan Stanley
New York
|
+$33M |
| 5 |
NMIMC
Northwestern Mutual Investment Management Company
Milwaukee,
Wisconsin
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$26.7M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$9.34M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.18M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.55M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.21M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CANY
151
Caxton Associates (New York)
New York
| – | -$713K | -39,128 | Closed |
|
|
HF
152
HRT Financial
New York
| – | -$651K | -35,761 | Closed |
|
|
FHA
153
Flagship Harbor Advisors
Boston,
Massachusetts
| – | -$619K | -34,000 | Closed |
|
|
NAM
154
Nexpoint Asset Management
Dallas,
Texas
| – | -$364K | -20,000 | Closed |
|
155
Walleye Trading
New York
| – | -$338K | -18,546 | Closed |
|
156
Jane Street
New York
| – | -$258K | -13,824 | Closed |
|
|
MLICM
157
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$141K | -7,752 | Closed |
|
|
RG
158
Retirement Group
San Diego,
California
| – | -$54K | -2,955 | Closed |
|
|
PHK
159
Point72 Hong Kong
Hong Kong
| – | -$52K | -2,866 | Closed |
|
160
Simplex Trading
Chicago,
Illinois
| – | -$31.9K | -1,713 | Closed |
|
|
MAM
161
Meeder Asset Management
Dublin,
Ohio
| – | -$19.3K | -1,038 | -98% |
|
|
ADIM
162
Alpha DNA Investment Management
Columbia,
Maryland
| – | -$2K | -163 | Closed |
|
ORGO Hedge Fund Activity: Q2 2021 in Review
142 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2021, worth a combined $823M — up 82% from $452M a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new ORGO positions and 20 closed out — a net gain of 41 holders — while 54 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $88.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $26.7M sold.
- 142 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2021, up from 101 in Q1 2021.
- Funds reported $823M of Organogenesis Holdings stock for Q2 2021, up 82% quarter-over-quarter.
- 61 funds opened new Organogenesis Holdings positions in Q2 2021 and 20 closed out, a net change of +41 holders.
- The largest Organogenesis Holdings buyer in Q2 2021 was BlackRock, an estimated $88.2M added.
- The largest Organogenesis Holdings seller in Q2 2021 was Avidity Partners Management, an estimated $26.7M sold.
Based on aggregated 13F filings for Q2 2021.